2010 CPT Changes for Paravertebral Facet Joint Injections & Guidance
CPT copyright 2008 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.
NCCI's most recent edits include significant changes for coding and billing facet joint injections. As of 2010, CPT codes for facet joint injections will include guidance for locating the injection site and will limit the number of levels that can be billed at three per day, according to Lynn Kuehn MS, RHIA, CCS-P, FAHIMA, a healthcare coding consultant with Murer Consultants.
Previous codes assigned for paravertebral joint injections did not include guidance that is used to help the physician locate the injection site, so guidance was billed separately for fluoroscopy (CPT 77003) or CT guidance (which actually did not have a code). Now, claims will be rejected if they include separate codes for the injection and guidance, according to Ms. Kuehn.
Codes for paravertebral facet joint injections, with guidance, are as follows:
• Cervical or thoracic injections:
o CPT 64490 — First or single level, with fluoroscopy or CT guidance
o CPT 64491 — Second level, with fluoroscopy or CT guidance
o CPT 64492 — Third and any additional levels, with fluoroscopy or CT guidance
• Lumbar or sacral injections:
o CPT 64493 — First or single level, with fluoroscopy or CT guidance
o CPT 64494 — Second level, with fluoroscopy or CT guidance
o CPT 64495 — Third and any additional levels, with fluoroscopy or CT guidance
According to Ms. Kuehn, physicians who do not use guidance to perform facet joint injections cannot use these CPT codes and instead must use musculoskeletal codes, such as codes for tendon sheath or trigger point injections (CPT 20550-20553).
Ms. Kuehn also says that some physicians may choose to use ultrasound guidance for facet joint injections. In those cases, the injections should be billed using Category III codes 0213T-0218T, which mirror CPT 64490-64495.
The information provided should be utilized for educational purposes only. Facilities are ultimately responsible for verifying the reporting policies of individual commercial and MAC/FI carriers prior to claim submissions.
Learn more about Murer Consultants.
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- Tenet shares jump 2.1%, Nobilis Health ranks as key vendor in global neurosurgery market & more — 5 ASC company notes
- 4 GI devices receive FDA clearance in January 2017
- Study: ACA did not impact employment rates through 2016
- CDC: 2016-2017 flu vaccine offers moderate protection
- Molina attributes $91M Q4 net loss to ACA marketplace: 4 highlights